Biomaterials Access Assurance Act of 1994

Read twice and referred to the Committee on Commerce.

Congressional Research Service

Official summary

Version 00 · Introduced in Senate · Jun 20, 1994

Biomaterials Access Assurance Act of 1994 - Declares that this Act applies to any civil action brought in either State or Federal court against a manufacturer, seller, or biomaterials supplier, or against a licensor of such suppliers for harm caused by an implant. Prescribes procedural guidelines and the burden of proof for actions against biomaterials suppliers for harm caused by an implant. Precludes such actions, except as provided under this Act, against a person who has neither registered with the Secretary of Health and Human Services nor included the implant on a list of devices filed pursuant to the Federal Food, Drug, and Cosmetic Act.

Read the summary on Congress.gov

PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

People & committees

Who introduced it

Sen. Lieberman, Joseph I. [D-CT] · D–CT

Committees

Commerce, Science, and Transportation Committee

6 cosponsorship records, including any withdrawals

Legislative record

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

Jun 20, 1994
Read twice and referred to the Committee on Commerce.
Jun 20, 1994
Sponsor introductory remarks on measure. (CR S7153-7154)
Jun 20, 1994
Introduced in Senate

Primary sources

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Introduced in Senate · Jun 20, 1994 Formatted Text PDF

Related bills identified by Congress.gov

HR 5092 · Biomaterials Access Assurance Act of 1994

Source last updated: Sep 8, 2026. Consult Congress.gov for the current record.

AI Conversation Starters

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze S.2215 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources

Discuss S.2215, 103rd Congress: Biomaterials Access Assurance Act of 1994

Official record: https://www.congress.gov/bill/103rd-congress/senate-bill/2215

Text version to examine: Introduced in Senate · 1994-06-20.

Official full text: https://www.congress.gov/103/bills/s2215/BILLS-103s2215is.htm

Imported record last updated by the source: 2026-09-08T18:05:37Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Analyze S.2215 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

Fairness and public impact

Progressive lens

Examine S.2215 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources

Discuss S.2215, 103rd Congress: Biomaterials Access Assurance Act of 1994

Official record: https://www.congress.gov/bill/103rd-congress/senate-bill/2215

Text version to examine: Introduced in Senate · 1994-06-20.

Official full text: https://www.congress.gov/103/bills/s2215/BILLS-103s2215is.htm

Imported record last updated by the source: 2026-09-08T18:05:37Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.2215 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

Institutions and government scope

Conservative lens

Examine S.2215 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources

Discuss S.2215, 103rd Congress: Biomaterials Access Assurance Act of 1994

Official record: https://www.congress.gov/bill/103rd-congress/senate-bill/2215

Text version to examine: Introduced in Senate · 1994-06-20.

Official full text: https://www.congress.gov/103/bills/s2215/BILLS-103s2215is.htm

Imported record last updated by the source: 2026-09-08T18:05:37Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.2215 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

Individual rights and government power

Liberty lens

Examine S.2215 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources

Discuss S.2215, 103rd Congress: Biomaterials Access Assurance Act of 1994

Official record: https://www.congress.gov/bill/103rd-congress/senate-bill/2215

Text version to examine: Introduced in Senate · 1994-06-20.

Official full text: https://www.congress.gov/103/bills/s2215/BILLS-103s2215is.htm

Imported record last updated by the source: 2026-09-08T18:05:37Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.2215 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.